DNAJB4 and breast carcinoma: DNAJB4 overexpression activates the Hippo signaling pathway, inhibits cancer cell proliferation and migration, and promotes TNBC cell apoptosis, suggesting its potential as a tumor suppressor and therapeutic target in breast cancer [15,16].